Global Animal Stem Cell Therapy Market 2023: Allogeneic Stem Cells Popular Sourcing Choice | Aratana Therapeutics, Inc., VetStem, Inc., Regeneus Ltd.

The animal stem cell therapy market refers to the use of stem cells in treating various diseases and injuries in animals. Stem cells have the ability to differentiate into different cell types and have shown promising results in the treatment of various animal health conditions such as osteoarthritis, tendon and ligament injuries, chronic inflammation and many more. The market is expected to grow due to increased investment in research and development, rising demand for animal-derived food products and increasing pet ownership worldwide. The growth of the market is also being driven by advances in stem cell technologies, such as regenerative medicine and tissue engineering, which have led to the development of new stem cell-based treatments for animals.

Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941

The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032).

Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that are given to animals. Hematopoietic stem cells and mesenchymal stem cells are used in these treatment procedures.

As the focus on giving animals a better quality of life grows, so does the adoption of such therapies across the world. The market for animal stem cell therapy is predicted to continuously increase owing to the growing need for higher levels of veterinary care.

Key Takeaways from Animal Stem Cell Therapy Market Study

Use of the mesenchymal stem cells, under the product type category for the animal stem cell therapy, is growing moderately. This segment held 71.1% market share by value in 2021.
Under the source category, high adoption of allogeneic stem cell therapy is being witnessed. Thus, the allogeneic source of animal stem cell therapy held the highest market share of 66.9% in 2021.
Osteoarthritis indication accounted for a market share of around 43.6% in 2021.
Increased adoption of canines is the reason this segment held the highest market share of 66.1% in 2021.
Under the end-user category, veterinary hospitals held 43.4% market share by value in 2021.
The Europe animal stem cell therapy market accounted for 31.5% of the global market share at the end of 2021.

"With rising disposable incomes and higher adoption rate of pet animals, the global market for animal stem cell therapy is set to gain traction over the coming years," says an analyst of Persistence Market Research.

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/14941

Market Competition

Key animal stem cell therapy providers are investing in innovating veterinary regenerative medicines and they are also coming up with new product launches for the well-being of animals.

Along with product innovation, market players are also aiming for various collaborations to strengthen their R&D in the field of animal stem cell therapy.

Boehringer Ingelheim, one of the key players in the animal stem cell therapy market, launched a new stem cell therapy that aims to improvise the healing capability of the tendon and suspensory ligament injuries in equines. This product, called RenuTend™, was launched in April 2022.

In April 2022, Exceed Equine collaborated with Medrego for determining stem cell treatments for a variety of ailments affecting performance horses.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the animal stem cell therapy market in its latest study, presenting historical demand assessment of 2012 - 2021 and projections for 2022 - 2032.

The research study is based on product type (hemopoietic stem cells and mesenchymal stem cells), source (allogeneic and autologous), indication (osteoarthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others), species (canine, feline, and equine), and end user (veterinary hospitals, veterinary clinics, and veterinary research institutes), across seven key regions of the world.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/14941

Competitive Landscape

The market for animal stem cell therapy is moderately fragmented with the presence of well-established players. The market is subject to high competition, and market players actively seek collaborative approaches for new product development to ensure increased product outreach.

Acquisitions and mergers within the industry further promote the market presence of manufacturers, thus propelling the overall industry.

In 2019, Medrego launched a new stem cell therapy product for the well-being of dogs. CaniCell is used for the treatment of osteoarthritis and other degenerative diseases in canines.
In 2019, Elanco Animal Health Incorporated acquired Aratana Therapeutics. This acquisition was completed to develop and commercialize innovative therapeutics for canines and felines.
In 2021, Boehringer Ingelheim partnered with PetMedix, a U.K.-based company involved in the antibody research & development of animal health.

For More Premium Insights, Check out the Link:

Medical Spa Market - https://www.medgadget.com/2023/01/navigating-the-booming-medical-spa-market-2023-trends-opportunities-and-challenges-dermani-medspa-lanserhof-tegernsee-chic-la-vie.html

Bioinks Market - https://www.medgadget.com/2023/01/bioinks-market-2023-is-estimated-to-surge-ahead-at-a-cagr-of-18-6-to-climb-to-a-market-size-of-us-738-2-mn-by-the-end-of-2032-pmr-study.html

Laboratory Developed Testing Market - https://www.medgadget.com/2023/01/laboratory-developed-tests-market-2023-over-two-fifths-market-revenue-generated-from-application-in-oncology-pmr-study.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.